ATP13A2 Products

Antibodies
Proteins
ATP13A2 Antibody Blocking Pep ...
ATP13A2 Antibody Blocking Peptide
NB110-41486PEP
Species: Hu
Applications: AC
Recombinant Human ATP13A2 GST ...
Recombinant Human ATP13A2 GST (N-T...
H00023400-Q01
Species: Hu
Applications: WB, ELISA, PA, AP
ATP13A2 Recombinant Protein A ...
ATP13A2 Recombinant Protein Antigen
NBP2-49149PEP
Species: Hu
Applications: AC

Description

Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.

Bioinformatics

Entrez Human
Uniprot Human
Human
Product By Gene ID 23400
Alternate Names
  • EC 3.6.3.8
  • FLJ26510
  • EC 3.6.3.5
  • Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome)
  • EC 3.6.3
  • KRPPD
  • EC 3.6.3.-
  • HSA9947
  • PARK9putative ATPase
  • probable cation-transporting ATPase 13A2
  • ATPase type 13A2

Research Areas for ATP13A2

Find related products by research area and learn more about each of the different research areas below.

Cancer
Neurodegeneration
Neuroscience
Plasma Membrane Markers
Signal Transduction

PTMs for ATP13A2

Learn more about PTMs related to ATP13A2.

Phosphorylation
Methylation
Ubiquitination

Bioinformatics Tool for ATP13A2

Discover related pathways, diseases and genes to ATP13A2. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.